Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma.
Authors: Worlikar T; Department of Radiology, University of Michigan, Ann Arbor, MI, USA. wtejaswi@umich.edu., Zhang M; Department of Radiology, University of Michigan, Ann Arbor, MI, USA., Yu M; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Kim H; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Shi J; Department of Pathology, University of Michigan, Ann Arbior, MI, USA., Hall TL; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA., Mendiratta-Lala M; Department of Radiology, University of Michigan, Ann Arbor, MI, USA., Cho CS; Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.; Executive Administration, University of Michigan Health-West, Wyoming, MI, USA.; Department of Cell Biology, Van Andel Institute, Grand Rapids, MI, USA., Xu Z; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Source: Scientific reports [Sci Rep] 2026 Apr 25; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 25.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-026-48331-7